CN Patent

CN112638368A — 制造哌仑他韦活性药物物质的方法

Assigned to AbbVie Inc · Expires 2021-04-09 · 5y expired

What this patent protects

本发明涉及哌仑他韦的组合物、其药物产品以及其制备方法和中间体。本发明涉及哌仑他韦的药物产品、活性药物物质、中间体和方法，哌仑他韦是一种可用于治疗丙型肝炎的NS5A抑制剂。

USPTO Abstract

本发明涉及哌仑他韦的组合物、其药物产品以及其制备方法和中间体。本发明涉及哌仑他韦的药物产品、活性药物物质、中间体和方法，哌仑他韦是一种可用于治疗丙型肝炎的NS5A抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN112638368A
Jurisdiction
CN
Classification
—
Expires
2021-04-09
Drug substance claim
No
Drug product claim
No
Assignee
AbbVie Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.